Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Bulletin Du Cancer
|
March 21, 2015
[Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers]
Mathilde Guerin, Renaud Sabatier, Anthony Gonçalves
Bulletin Du Cancer
|
July 6, 2026
[Update: Evolution in the management of metastatic urothelial carcinomas]
Clémentine Gaucher, Cécile Vicier, Mathilde Guerin
World Journal of Surgical Oncology
|
October 1, 2013
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up
Mathilde Guerin, Naji Salem, Jochen Walz, et al.
Cancers
|
June 18, 2020
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi
Essia Mezni, Cécile Vicier, Mathilde Guerin, et al.
Frontiers in Immunology
|
October 3, 2022
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report
Roxane Mari, Mathilde Guerin, Cécile Vicier, et al.
World Journal of Urology
|
June 27, 2020
Metastatic hormone sensitive prostate cancer: local treatment strategies
Jochen Walz, Geraldine Pignot, Sami Fakhfakh, et al.
Expert Review of Proteomics
|
November 5, 2016
How may targeted proteomics complement genomic data in breast cancer?
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Oncotarget
|
May 12, 2015
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine Pasero, Gwenaëlle Gravis, Samuel Granjeaud, et al.
Frontiers in Oncology
|
October 26, 2019
Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma
Emilien Billon, Jochen Walz, Serge Brunelle, et al.
Journal of Translational Medicine
|
December 5, 2025
The plasma nanoDSF denaturation profiles predict the presence of breast cancer
Mathilde Guerin, Rémi Eyraud, Philippe Tsvetkov, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Bulletin Du Cancer
|
March 21, 2015
[Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers]
Mathilde Guerin, Renaud Sabatier, Anthony Gonçalves
Bulletin Du Cancer
|
July 6, 2026
[Update: Evolution in the management of metastatic urothelial carcinomas]
Clémentine Gaucher, Cécile Vicier, Mathilde Guerin
World Journal of Surgical Oncology
|
October 1, 2013
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up
Mathilde Guerin, Naji Salem, Jochen Walz, et al.
Cancers
|
June 18, 2020
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi
Essia Mezni, Cécile Vicier, Mathilde Guerin, et al.
Frontiers in Immunology
|
October 3, 2022
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report
Roxane Mari, Mathilde Guerin, Cécile Vicier, et al.
World Journal of Urology
|
June 27, 2020
Metastatic hormone sensitive prostate cancer: local treatment strategies
Jochen Walz, Geraldine Pignot, Sami Fakhfakh, et al.
Expert Review of Proteomics
|
November 5, 2016
How may targeted proteomics complement genomic data in breast cancer?
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Oncotarget
|
May 12, 2015
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine Pasero, Gwenaëlle Gravis, Samuel Granjeaud, et al.
Frontiers in Oncology
|
October 26, 2019
Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma
Emilien Billon, Jochen Walz, Serge Brunelle, et al.
Journal of Translational Medicine
|
December 5, 2025
The plasma nanoDSF denaturation profiles predict the presence of breast cancer
Mathilde Guerin, Rémi Eyraud, Philippe Tsvetkov, et al.
Page
of 2